ALBAlbemarle Corporation
$101.29+26% 1Y
$101.29
$79.4852 weeks$215.07
ALB as reported
Albemarle Corporation reported $5.91B of revenue over the trailing twelve months, +18% on the year before. 11 reported series are charted on this page, each one as filed.
$5.91B
Revenue, trailing twelve months · to Q2 2026 · +18% against the twelve months before
- Net income
- $224M
Net income · −124% year on year · trailing twelve months to Q2 2026
- Free cash flow
- $1.34B
Free cash flow · −817% year on year · trailing twelve months to Q2 2026
- Operating margin
- 2.6%
Operating margin · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $5.91B | +18% | Q2 2026 |
| Net income | $224M | −124% | Q2 2026 |
| EPS | $0.26 | −103% | Q2 2026 |
| Gross margin | 23% | n/a | Q2 2026 |
| Operating margin | 2.6% | n/a | Q2 2026 |
| Net margin | 2.1% | n/a | Q2 2026 |
| ROE | −1.4% | n/a | Q2 2026 |
| ROA | −0.84% | n/a | Q2 2026 |
| ROIC | −0.71% | n/a | Q2 2026 |
| Free cash flow | $1.34B | −817% | Q2 2026 |
| P/E | 17.1 | n/a | Q1 2024 · 9 quarters behind |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.

Albemarle Corporation (ALB) · Revenue and profitRevenue and profitAlbemarle Corporation (ALB)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
Specialty Chemicals
The closest names by size in the same industry